Color Atlas Of Immunology

!"#"$ %&#'( ") *++,-"#"./ !"#$%&' ($)*"# +'#,"-."#/ 0121 3#45"--4# 45 0"$)6)7" 89:#)." ; 45 +"#A)7 +"#A)7/ !"#,:7>

C7.47)4 3"DD'..4/ 0121 3#45"--4# 45 ?",:.4A4*> :7$ E764A4*> 89:#)." ; 45 +"#A)7 +"#A)7/ !"#,:7>

F).9 647.#)B'.)47- B> G),4 %*B$% E"37,$; .,� 8.%02(55< .7, 6%*2(%3.2$,$R- /,%(/,.- %33'68%*&"*+ ,%37 B$2+ %*B .' 37,3?; "( *,3,--%$& "* 3'*-2/.%."'* \".7 % 87&-"3"%* '$ -8,3"%/"-.; \7,.7,$ .7, B'-%+, -37,B2/,- 6,*."'*,B .7,$,"* '$ .7, 3'*.$%"*B"3%0 ."'*- -.%.,B #& .7, 6%*2(%3.2$,$- B"((,$ ($'6 .7, -.%.,6,*.- 6%B, "* .7, 8$,-,*. #''?= J237 ,>%60 "*%."'* "- 8%$."32/%$/& "68'$.%*. \".7 B$2+- .7%. %$, ,".7,$ $%$,/& 2-,B '$ 7%5, #,,* *,\/& $,/,%-,B '* .7, 6%$?,.= c5,$& B'-%+, -37,B2/, '$ ,5,$& ('$6 '( %88/"3%."'* 2-,B "- ,*."$,/& %. .7, 2-,$R'\* $"-? %*B $,-8'*-"#"/".&= 97, %2.7'$- %*B 82#0 /"-7,$- $,d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

1$"*.,B "* D,$6%*& #& D$%66/"37; 1/",K7%2-,* @JAS V0LV0LTZYXL0U `D9Fa @JAS U0NZbYY0MZX0V `9S]a L T V X b

Burmester, Color Atlas of Immunology © 2003 Thieme All rights reserved. Usage subject to terms and conditions of license.

"

%0",& &12 %,&1"$(

)*+,-./0,$1*+ 2/+3*4&*+

5(&'($' 6*77/&&'

?0%6@A( B 6&70% C(%,0)$0% \%- #'$* "* _%*'5,$; D,$6%*& "* LMb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d2,-."'*- "* 3/"*"3%/ 6,B"3"*, %*B /%#'$%.'$& 8$%3."3,=

97, 5.'"%.$"%< .--5&8.$&"#) -,3."'* B,-3$"#,.7, 6'-. "68'$.%*. .,-. -&-.,6- "* "662*'/'+&= f)'*5,*."'*%/g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

97, 2(#6.,0#$.5 -%&-50) -,3."'* #,+"*- \".7 .7, '$+%*- '( .7, "662*, -&-.,6; ('//'\,B #& % B,0 -3$"8."'* '( .7, $,/,5%*. 3,//- '( .7, "662*, -&-.,6 %*B .7, 6,37%*"-6- #& \7"37 9 %*B A /&687'3&.,%3d2"$, 7"+7 /,5,/- '( -8,3"("3".&= J2$(%3, 6'/,32/,%$, B,-3$"#,B "* B,.%"/ "* B,(,$,*3, .' .7, ,*'$0 6'2- ,687%-"- 8/%3,B '* .7,6 "* 6'-. "662*'0 /'+"3%/ 82#/"3%."'*-= E B,-3$"8."'* '( %33,--'$& 3,//%*B *%.2$%/ ?"//,$ 3,//- ('//'\-= S,>.; .7, 726%* /&687'3&., %*."+,* -&-.,6 "- %*%/&K,B; ('//'\,B #& .7, 8$"*3"8/,- '( %*."+,* 8$'3,--"*+ %*B 7&8,$0 -,*-"."5".& $,%3."'*-= E2.'"662*".& %*B .'/,$%*3, %$, B,-3$"#,B "* .7, /%-. 8%$. '( .7, -,3."'*=

Burmester, Color Atlas of Immunology © 2003 Thieme All rights reserved. Usage subject to terms and conditions of license.

!7

!"-&2-&( #$%&'()%*'+ ,-.%/.0+)1 D10 +,,(#0 K
49 49_ cEc cE: cAF c) c)1 cDC c!@JE c<E cSE cW cJW CE)J C3`!k"a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`,((,3.a 726%* %*."62$"*, %*."#'B& 7,8%."."- ) 5"$2_'B+?"*R- B"-,%-, 7"+7 ,*B'.7,/"%/ 5,*2/,726%* "662*'B,("3",*3& 5"$2726%* /,2?'3&., %*."+,* 7,%.0-7'3? 8$'.,"* 7,$8,- -"68/,> 5"$2726%* 90/&687'.$'8"3 5"$2"662*, 3'68/,> "*.,$3,//2/%$ %B7,-"'* 6'/,32/, "*.,$/,2?"*0L&03'*5,$."*+ ,*K&6, "*.,$B"+".%."*+ 3,// "*-2/"*0B,8,*B,*. B"%#,.,- 6,//".2"*.,$(,$'* "662*'+/'#2/"*

Burmester, Color Atlas of Immunology © 2003 Thieme All rights reserved. Usage subject to terms and conditions of license.

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Ƶ"0 #1 "(-0 1-&0": .-*' 4'1'*0' )&' 5()6#7/"#0'4 9/ %)7()6'0;

-%&'()(' *++,#& -.$/&+ A(' 5'00 #1 037( )* -%%3*' &'05#*0' 5)2'0 "(' >)/ 1#& "(' 05'7-1-7 -%%3*' &'05#*0'; !* ) 05'7-1-7 7/"#$-*' '*2-&#*%'*"< "(' 9#4/ 7)* 4': 7-4' >('"('& "# 5''4 "# ) %#&' (3%#&). .-*' #1 4'1'*0' #& ) %#&' 7'..3.)& .-*' #1 4'1'*0'; A(' %-6&)"-#* #1 )*"-6'*:5&'0'*"-*6 7'..0 B@OPC "# "(' ./%5(#-4 #&6)*0 1-&0" "&-66'&0 ) 0/0"'%-7 -%%3*' &'05#*0'< "('* ) 1$1"%2 %$0+"'0$; A(' 05'7-1-7 -%%3*' 0/0"'% 7#*0-0"-*6 #1 A )*4 Q ./%5(#7/"'0 -0 &'05#*0-9.' 1#& "(-0; A('0' 7'.. 0/0"'%0 7)* 5Ƶ' (-6(./ 05'7-1-7 &')7: "-#*0 "# "('-& &'05'7"-2' )*"-6'*0 )*4 3*4'&6# 7.#*). '85)*0-#*< "(30 )7(-'2-*6 ) (-6(./ '11'7: "-2' &'05#*0' "# )*4 %'%#&/ 1#& "(#0' )*"-6'*0;

! 2,#34+&#/45 67(#'(%5&$

01& *++,#& -.$/&+

"

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

Burmester, Color Atlas of Immunology © 2003 Thieme All rights reserved. Usage subject to terms and conditions of license.

! " 8

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

Burmester, Color Atlas of Immunology © 2003 Thieme All rights reserved. Usage subject to terms and conditions of license.

#?+$?%+@

CD34+

Pluripotent stem cell

Myeloid progenitor

Megakaryocyte

!

Lymphoid progenitor

Myeloblast

T-cell precursor

Monoblast

Thymus

B-cell precursor

Platelets B lymphocytes

P

h

Erythrocytes

a

g

o

c

y

t

e

s T lymphocytes

Basophils Eosinophils

Dendritic Neutrophils Monocytes cells A. Origin of cells of the immune system Innate immunity

Adaptive immunity

Infectious agents

Phagocytes

Natural killer cells

;2'+ $"# /+$/0#+)* (#+(#= $"# $"%&'( 2#?#./4( -( -+ /'$0,/9$" /1 $"# $"),2 8,-+*")-. 4/'*" -+2 .-$#, &)0,-$#( $",/'0" $"# -+$#,)/,  )-($)+'& $/ )$( 1)+-. 2#($)+-$)/+ 8#$9##+ $"# ($#,+'& -+2 $"# &-@/, ?#((#. $,'+7(5 >$ */+()($( /1 $9/ ./8#( $"-$ '+)$# *,-+)-..% $/ 1/,& $"# "/,+( /1 $"# $"%&'(= 9")*" (/&#$)&#( #A$#+2 $/ $"# $"%,/)2 0.-+25 " !"# ()B# /1 $"# $"%&'( )( -0#32#4#+2#+$5 >$ ,#-*"#( - &-A)&'& 9#)0"$ /1 -,/'+2 CD 0 -,/'+2 $"# ED$" %#-, /1 .)1# -+2 $"#+ '+2#,0/#( - */+$)+'/'( 4,/*#(( /1 )+?/.'$)/+5 F( - ,#('.$= $"# 4-,#+*"%&- /1 $"# $"%&'( */+()($( -.&/($ #+$),#.% /1 1-$ -+2 1)8,/'( $)(('# )+ /.2 -0#5 G+.% - 1#9 *.'($#,( /1 4-,#+*"%&- -+2 .%&4"/*%$#( ,#&-)+ )+$-*$ ;(## -.(/ 4-,-0,-4"( # -+2 $+ &-+% *-(#(= )$ )( +/$ 4/(()8.# $/ ,#.)-8.% 2)11#,#+$)-$# 8#$9##+ $"# )+?/.'$#2 /,0-+ -+2 $"# (',,/'+2)+0 )-($)+-. 1-$ 8% &-*,/3 (*/4)* &#-+(5 #= $ H-*" ./8# /1 $"# $"%&'( )( ('82)?)2#2 8% 1)8,/'( (#4$- ;$,-8#*'.-#< )+$/ (&-..#, ./8#(= #-*" /1 9")*" */+()($( /1 -+ /'$#, .-%#, ;*/,$#A< -+2 -+ )++#, .-%#, ;'..-$ -.(/ */+$-)+( ($,'*$',#( 7+/9+ -( J-((-..K( 8/2)#( $"-$ -,# &-2# /1 2#+(#.% 4-*7#2 *#.. .-%#,(5 !"#(# ($,'*$',#( &-% 8# $"# ,#&+-+$( /1 2#0#+#,-$#2 #4)$"#.)-. *#..(5 F+ )+$,-$"%&)* 8-,,)#, ()&).-, $/ $"# 8.//2L8,-)+ 8-,,)#, 2)?)2#( $"# */,$#A 1,/& $"# *),*'.-$)+0 8.//25 M/ ('*" 8-,,)#, #A)($( 1/, $"# &-,,/95 !"# .%&4"/*%$#( $"-$ &-$',# )+$/ ! *#..( )+ $"# $"%&'( -,# /1$#+ *-..#2 !"#$%&#!'( 1/, 1'+*$)/+-. -+2 -+-$/&)*-. ,#-(/+(5 !"# (4#*)1)* */&8)+-$)/+ /1 )&4/,$-+$ (',1-*# &-,7#,( 4#,&)$( )&&'+/4"#+/$%4)* 2)11#,#+3 $)-$)/+ 8#$9##+ $"%&/*%$#( -+2 &-$',# ! *#..(5 !"%&/*%$#( -,# #A$,#&#.% */,$)(/+#3(#+()$)?#

)+ $"# #-,.% ($-0#( /1 2#?#./4&#+$ ;)&4/,$-+$ 1/, &-$',-$)/+ ($'2)#( 66 *'0 68=>

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� 4%30.*,)1 20((#3(%4: ;"(9" 9/')*(' * ,#+.('*& 9#')#+ .*0# /A 3&*$)(9 #&#.#')$ 19#')+/9-)#$

*'0 9#')+/3&*$)$= *'0 * .*')&# 2/'# .*0# /A $.*&& &-.%"/9-)#$>

6" 7&')589855)':8$(4 012,+):4 ;:55&( ! &-.%"/9-)#$ *+# .*('&- &//$#&- 0($)+(34)#0 )"+/4,"/4) )"# (')#+A/&&(94&*+ )($$4#B $/.# *+# *&$/ A/4'0 (' )"# (')+*#%()"#&(*& +#,(/'> !"# '4.3#+ /A (')+*#%()"#&(*& &-.%"/9-)#$ *'0 %&*$.* 9#&&$ ('9+#*$#$ 0+*.*)(9*&&- ;"#' ('@ A&*..*)(/' /994+$>

Burmester, Color Atlas of Immunology © 2003 Thieme All rights reserved. Usage subject to terms and conditions of license.

A(%:,+(%8- >%?8.5

Germinal center

White pulp

Sinus

Lymphoid follicle

Arteriole Follicular mantle

Mantle zone

Marginal zone

Marginal zone

B

B Periarterial lymphatic sheath

1. Anatomic structure

B T

B Germinal center

T

T

T

2. Cross-section through arteriole and follicle; lymphocyte circulation

A. Structure of the spleen Capsule

Secondary follicle Paracortex

Marginal sinus Interfollicular sinus

Afferent lymphatic

Medullary sinus Primary follicle

@&.482(.$8- A%:.':,-(5

Red pulp

!

"

Efferent lymphatic

1. Inactive lymph node

2. Active lymph node

B. Structure of the lymph node Follicle center

M cells

Mantle zone

Follicle-associated epithelial cells Dome region

T-cell zone

Postcapillary venule Muscular mucosa

Efferent lymphatic

1. GALT: Gut-associated1. lymphoid tissue; Peyer’s patch C. Mucosa-associated lymphoid tissue

2. BALT: Bronchus-associated 2. lymphoid tissue

Burmester, Color Atlas of Immunology © 2003 Thieme All rights reserved. Usage subject to terms and conditions of license.

! " C

=&*